Accuray Inc (ARAY)
1.89
+0.06
(+3.28%)
USD |
NASDAQ |
Nov 21, 16:00
1.895
0.00 (0.00%)
After-Hours: 20:00
Accuray Enterprise Value: 301.10M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 301.10M |
| November 20, 2024 | 295.06M |
| November 19, 2024 | 296.07M |
| November 18, 2024 | 281.99M |
| November 15, 2024 | 281.99M |
| November 14, 2024 | 286.01M |
| November 13, 2024 | 293.05M |
| November 12, 2024 | 303.11M |
| November 11, 2024 | 310.15M |
| November 08, 2024 | 327.25M |
| November 07, 2024 | 321.21M |
| November 06, 2024 | 315.18M |
| November 05, 2024 | 304.12M |
| November 04, 2024 | 292.05M |
| November 01, 2024 | 287.02M |
| October 31, 2024 | 284.78M |
| October 30, 2024 | 299.85M |
| October 29, 2024 | 297.84M |
| October 28, 2024 | 298.84M |
| October 25, 2024 | 286.79M |
| October 24, 2024 | 286.79M |
| October 23, 2024 | 286.79M |
| October 22, 2024 | 288.80M |
| October 21, 2024 | 296.84M |
| October 18, 2024 | 300.85M |
| Date | Value |
|---|---|
| October 17, 2024 | 294.83M |
| October 16, 2024 | 301.86M |
| October 15, 2024 | 298.84M |
| October 14, 2024 | 291.81M |
| October 11, 2024 | 294.83M |
| October 10, 2024 | 290.81M |
| October 09, 2024 | 287.80M |
| October 08, 2024 | 295.83M |
| October 07, 2024 | 299.85M |
| October 04, 2024 | 302.86M |
| October 03, 2024 | 288.80M |
| October 02, 2024 | 288.80M |
| October 01, 2024 | 283.78M |
| September 30, 2024 | 291.81M |
| September 27, 2024 | 283.08M |
| September 26, 2024 | 279.07M |
| September 25, 2024 | 274.05M |
| September 24, 2024 | 281.07M |
| September 23, 2024 | 281.07M |
| September 20, 2024 | 277.05M |
| September 19, 2024 | 294.10M |
| September 18, 2024 | 295.10M |
| September 17, 2024 | 294.10M |
| September 16, 2024 | 322.17M |
| September 13, 2024 | 323.17M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
209.57M
Minimum
Mar 24 2020
627.73M
Maximum
Nov 04 2021
374.95M
Average
361.20M
Median
Nov 21 2023
Enterprise Value Benchmarks
| Baxter International Inc | 28.43B |
| Boston Scientific Corp | 143.48B |
| Perspective Therapeutics Inc | -63.40M |
| Xtant Medical Holdings Inc | 85.83M |
| Catheter Precision Inc | 3.891M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.954M |
| Revenue (Quarterly) | 101.54M |
| Total Expenses (Quarterly) | 103.69M |
| EPS Diluted (Quarterly) | -0.04 |
| Gross Profit Margin (Quarterly) | 33.94% |
| Profit Margin (Quarterly) | -3.89% |
| Earnings Yield | -8.99% |
| Normalized Earnings Yield | -9.404 |